Announcements and latest updates

Guideline updates:

For new, updated and removed guidance for the last month click here

the Pink One

Newsletter for NHS Highland Prescribers: Click here (NHS Highland Intranet access required).

Home
THERAPEUTIC GUIDELINES
THERAPEUTIC GUIDELINES
COVID-19 (Coronavirus)
Back
Treatment (COVID-19)
Antivirals and neutralising Monoclonal Antibodies (nMABs) for COVID-19

Antivirals and neutralising Monoclonal Antibodies (nMABs) for COVID-19

11.04.2023

Please note: Although intravenous remdesivir is included in the guidance, this drug is not available for delivery in the community setting in NHS Highland. An update on the use of remdesivir within current NICE Guidance is awaited, pending an appeal by the manufacturer.

20.07.2022

Please note: Due to concerns over the efficacy of sotrovimab against the current circulating Omicron variants of SARS-CoV-2 (BA.2 and others), sotrovimab is not currently being offered routinely. Please discuss any individual patient requirements with one of the Infectious Diseases consultants.

Guideline updates:

the Pink One

Antivirals and neutralising Monoclonal Antibodies (nMABs) for COVID-19

Non-hospitalised patients with symptomatic COVID-19 infection

Hospital in-patients admitted with symptomatic COVID-19 infection

Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection